Summary: Ionised and total magnesium concentrations were determined in the serum of different groups of patients suffering from renal or hepatic diseases. Ionised magnesium was measured by Microlyte 6 (KONE, Espoo, Finland) and total magnesium by atomic absorption spectrometry.
Introduction
circumstances in which the concentration of active mag-. ,.
, . nesium ions is decreased or the less meaningful pseudoRenal as well as hepatic diseases may have an .mpact h esaemia be ted . on magnesium balance. As long as only total magnesium concentration could be determined (1-7), there were always some doubts as to whether alterations reflected changes of the ionised (unbound) magnesium concentra-Materials and Methods tion or the protein-bound concentration. As in the case , * , -ι . ^ ι · · j Patients of calcium, a decrease or an increase of the ionised magnesium concentration may be considered as a "true" Renal diseases change, whereas a decrease of the total magnesium con-L Group (RD , ): 21 patients (14 male) with renal diseascs centration due to a reduction of protein-bound magne-(tab. I) and hypoalbuminaemia (albumin in the serum < 37 g/l) but sium might be called a "pseudohypomagnesaemia". On "normal'* creatinine clearance (after adjustment to 1.73 m 2 body , ^ r j A , ^ , . A A . surface) were investigated (tab. 2). Patients suffering at the same the other hand, the total magnesium concentration may time from gastro . intestina i diseaseSj hypo . or hyperthyroidism or lie within the reference interval, while the ionised con-diabetes mellitus were excluded, as well as patients treated with centration, reflecting the active magnesium ions, is low-cycJosporin (only two cases), cisplatin or calcium concentrations , , -. ι v· j· ·* * -A L exceeding 2.60 mmol/1 serum, ered, because of complex binding, e. g. to citrate m the event of massive transfusion of blood during liver trans-2. Group (RD 2): 29 patients (19 male) with renal diseases plantation (8) . In this study, ionised and total magnesium < . , . · j · · justed to 1.73 m 2 body surface) were investigated (tab. 2). They concentrations m the serum were determined in patients were under Λί|οηβη1 with furoscmidc (mean dosage 103 mg/d; suffering from liver or kidney diseases, to determine the range 40-250 mg/d). For exclusion criteria see RD 1. 
Liver diseases
The following groups with liver diseases were examined (for exclusion criteria see RD 1):
1. Group (LD 1): 51 patients (31 male) with diseases of the liver (tab. 3) and hypoalbuminaemia, but "normal" creatinine concentration in the serum (tab. 4).
The groups were compared with a group of 60 blood donors, who were selected according to the guidelines (9) and matched for age (mean ± standard deviation (years): 46.5 ± 12.2)) and sex (34 male, 26 female).
Sampling
Blood was obtained from the patients and the blood donors between 7 a. m. and 9.30 a. m. by venipuncture with Monovettes (Sarstedt, Nümbrecht). The serum was separated after centrifugation (25 °C, 1200 g) and stored in a refrigerator (max. 5 days), if analyses could not be performed at once.
Sample preparation
Serum for ionised magnesium measurement was adjusted to pH 7.40 ± 0.05 by bubbling CO 2 gas prior to analysis.
Methods

Ionised magnesium
The concentration of ionised magnesium in the serum was determined by Microlyte 6 (KONE, Espoo, Finland). The ion-selective electrode which was used for the measurement had a modified ETrt 5220-containing PVC membrane. An Ag/AgCl-electrode was used as a reference electrode. The ionised calcium concentration was determined simultaneously, since this'is needed to account for S-Aspartate aminotransferase/S-Alanine aminotransferase the common calcium interference of the magnesium electrode. As the degree of interference may change with time, the actual degree at the time of measurement was determined by measurement of standards (without protein) containing different concentrations of calcium and magnesium just prior to the determination. Ionised magnesium concentrations are reported for the actual pH of the sample and for pH 7.40 after calculation by a built-in computer. In this study ionised magnesium concentration is given after adjusting to pH 7.4, to make comparison with the reference interval easier.
Other quantities
Ionised calcium, pH, ionised sodium and ionised potassium in serum were determined simultaneously with ionised magnesium by Microlyte 6 (KONE, Espoo, Finland).
Total magnesium in serum and urine was determined by atomic absorption spectrometry (AAS 1100, Perkin-Elmer, Uberlingen), at 285.2 nm after addition of LaCl 3 .
Albumin concentration in serum was determined by immunochemistry (Array, Beckman Instr., M nchen).
Creatinine concentration in serum was measured enzymatically (Hitachi 747, Boehringer Mannheim, Mannheim).
Total calcium was determined after reaction with cresolphthalein complexone (Hitachi 747, Boehringer Mannheim, Mannheim).
Total protein in serum was measured bichromatically by the biuret reaction (Hitachi 747, Boehringer Mannheim, Mannheim).
Cholesterol and triacylglycerol in serum were determined enzymatically (Hitachi 747, Boehringer Mannheim, Mannheim).
Bilirubin was measured bichromatically after reaction with 2.5-dichlorphenyldiazonium salt (Hitachi 747, Boehringer Mannheim, Mannheim).
Enzymes (aspartate aminotransferase, alanine aminotransferase, cholinesterase) were determined according to the standard procedures of the German Society for Clinical Chemistry.
Creatinine concentration in urine was measured by Jqffe's reaction (Elan, Eppendorf, Hamburg).
Total protein in urine was determined with the biuret reaction after precipitation with trichloroacetic acid and blank correction.
Quality assessment Precision
Kontrollogen-L (lot 623136) (Behring, Frankfurt/M.), and Qualitrol Precision (Merck, Darmstadt) were used for assessment of precision. All measurements of the ionised magnesium concentrations were performed in duplicates, which were accepted, if their values differed by less than 2%.
Statistics
Data of the different groups were compared by analysis of covariance and Scheffe's test (10) . Adequate Gaussian distribution was tested by the Kolmogorov-Smirnov-test.
Results
Quality assessment
Precision
Two control sera were analysed on 10 consecutive days in duplicate. The coefficient of variation for ionised Clinical study
Reference interval
The reference intervals for total and ionised magnesium were calculated from data of 60 healthy blood donors and include the range between the 2.5th and 97.5th percentile (tab. 6). There was no significant influence of age or sex on the reference interval of ionised and total magnesium nor on the pertinent ratio as proven by analysis of covariance. The same held true for the following groups of patients.
Renal diseases
Ionised and total magnesium concentrations in the serum of patients suffering from renal diseases are presented in table 7.
In patients with proteinuria (RD 1) and decreased albumin concentration in the serum, the total magnesium concentration was 9% lower (statistically significant) than in the reference group, whereas the ionised magnesium concentration was almost identical (-1%, statistically not significant); therefore the percentage of ionised magnesium was increased. Figure 1 indicates that total magnesium is dependent on albumin concentration, UC-ER: difference between magnesium concentration in superna^· tant after ultracentrifugation (determined by AAS) and complexed magnesium concentration as obtained from exchange resin (ER) (determined by AAS). whereas the ionised magnesium concentration is not influenced.
In renal insufficiency (RD 2) both, jthe ionised and total magnesium concentration in the serum were equally ele- vated (4-15.6% vs + 16.2%) (tab. 7) as compared with the reference group, and the fraction of ionised magnesium was unchanged. Nevertheless, the dependency of total magnesium on albumin concentration in the serum was still obvious ( fig. 2 ). Magnesium excretion in the urine was below the reference interval (2.5-8.5 mmol/d) and lower than in the patients with proteinuria (RD 1), but the mean fractional excretion (7.0% ± 3.9% (standard deviation)) exceeded group RD 1 (3.5% ± 1.2% (standard deviation)).
Liver diseases
Ionised and total magnesium concentrations in the serum of patients suffering from liver diseases are presented in table 8.
In group LD 1 with normal renal function but with hypoalbuminaemia, the total magnesium concentration was decreased by 6.2% as compared with the reference interval, and the ionised magnesium concentration was decreased by only 2.7% (statistically not significant). Hence, the ionised magnesium fraction was elevated. It may be concluded that total magnesium is correlated with the albumin concentration ( fig. 3 ), whereas ionised magnesium is not significantly affected.
In liver diseases combined with renal insufficiency (and therapy with furosemide), LD 2 results resembled RD 2: the mean concentration of ionised and total magnesium were increased similarly (17% vs 13.8%), and the ionised magnesium fraction was not significantly changed. Correlation of total magnesium and albumin concentration may be supposed from figure 4.
In patients treated with cyclosporin (LD 3), the decrease of total magnesium concentration exceeded the decrease of ionised magnesium (-17.5% vs -11.3%), and the fraction of ionised magnesium was significantly elevated (7.0%). Its correlation with albumin is presented in figure 5 .
In cases of treatment with furosemide and spironolactone (LD 4) only the total magnesium concentration was significantly changed (-7.5%) and hence the fraction of ionised magnesium was elevated (+ 5.6%). It was poorly correlated with the albumin concentration (figure 6 ).
During therapy of 9 patients with spironolactone as the only diuretic (LD 5), ionised magnesium was slightly decreased (1.9%), but total magnesium was clearly (8.8%) lowered (but statistically not significant with only 9 patients), and the fraction of free magnesium was significantly elevated. Because of the small number of patients the correlation with albumin may be misleading and is not shown.
In patients treated with diuretics and substituted with magnesium (LD 6), ionised magnesium was not significantly elevated, total magnesium not significantly lowered, and the fraction of ionised magnesium not significantly increased but correlated with the albumin concentration ( fig. 7) .
Discussion
Before starting the study the reliability of the measurement of ionised magnesium was evaluated. According to the guidelines (11), the pertinent coefficient of variation should not exceed 2.1%. In fact 2.2% and 2.0% were achieved. Accuracy could not be directly checked as no appropriate control sera are available. But there was indirect evidence that determinations were accurate (see results). Precision and accuracy of the other methods was better than required by the guidelines (11) (data not shown).
Blood samples from all individuals were taken between 7 a. m. and 9.30 a. m. to exclude any influence of possible circadian rhythms. 
Renal diseases
In patients with "normal" serum creatinine concentration and proteinuria (RD 1) it may be supposed that the total magnesium concentration is lowered due to hypoalbu- minaemia ("pseudohypomagnesaemia"). Indeed, the ionised magnesium concentration did not differ significantly from the normal concentration, and the ratio: ionised magnesium/total magnesium was inversely correlated with the albumin concentration. This ratio minimises the impact of many other factors which similarly influence total and ionised magnesium. Hence it can be more clearly demonstrated that albumin concentration only affects the total magnesium concentration, i.e. total magnesium concentration was directly correlated with the albumin concentration. Of course, the correlation was not very strong, as ionised and total magnesium are more closely related.
In renal insufficiency, hypermagnesaemia was observed due to a reduced glomerular filtratation rate of ultrafilterable magnesium, which was only partly counterbalanced by an increased fractional excretion rate. As ionised magnesium is the most important fraction of ultrafilterable magnesium, its concentration also rose, as well as the concentration of total magnesium which is in equilibrium with ionised magnesium. Apart from the decisive influence of renal function on the magnesium concentration, the role of albumin was still demonstrable ( fig. 2) , with the ionised magnesium fraction inversely correlated with the albumin concentration.
Liver diseases
In liver diseases associated with hypoalbuminaemia and normal renal function (LD 1), "pseudohypomagnesaemia" may be diagnosed for the same reasons as in the RD 1-group. The changes were less distinct, as hypoalbuminaemia was less pronounced. In cases of concomitant renal insufficiency, changes resembled those in the RD 2-group -with albumin still exerting an influence.
In patients treated with cyclosporin (LD 3) renal loss of (ultrafilterable) magnesium was evident. Both the ionised and the total magnesium concentration were lowered. However, due to hypoalbuminaemia, the decrease of total magnesium exceeded the decrease of ionised magnesium and the fraction of ionised magnesium was elevated.
During treatment with an aldosterone antagonist alone or in combination with furosemide (LD 4, LD 5), a normal ionised magnesium concentration was maintained, whereas the total magnesium concentration (affected by the decreased albumin concentration) suggested magnesium deficiency. If treatment with an aldosterone antagonist was accompanied by magnesium administration, the ionised magnesium concentration exceeded (not significantly) the normal concentration; the total magnesium concentration was closer to normal, but it did not attain a normal value on account of the reduced proteinbound fraction.
It may be concluded that an increased concentration of total magnesium is usually accompanied by an increase of ionised magnesium, e. g. in renal insufficiency. A decreased total magnesium concentration is quite often the result of "pseudohypomagnesaemia", which arises from hypoalbuminaemia with a normal ionised magnesium concentration. Among the patients investigated, a decreased ionised magnesium concentration was observed only in patients receiving cyclosporin, i. e. these patients suffered a true magnesium deficiency due to renal loss. As "true" hypomagnesaemia (i.e. decreased ionised magnesium concentration) was not observed in the more severe stages of renal and hepatic diseases with distinct hypoalbuminaemia, it may be assumed that the less serious stages are also not associated with "true" hypomagnesaemia. This means that "true" hypomagnesaemia is not to be expected in renal diseases, whereas "true" hypermagnesaemia is likely to develop in cases of reduced glomerular filtration rate.
In the same way severe liver diseases with or without treatment with diuretics (furosemide and/or spironolactone) usually do not lead to "true" hypomagnesaemia, apart from cyclosporin treatment after orthotopic liver transplantation. The influence of free fatty acids is obviously of minor importance. The investigated diseases are not typically accompanied by a change in free fatty acid concentration. A decrease of ionised magnesium concentration was not encountered, except in cyclosporin treatment when it paralleled the total magnesium concentration. Therefore, it is recommended that decreased total magnesium concentrations are further investigated by measurement of the ionised magnesium concentration. Calculation of ionised magnesium from total magnesium and albumin may be erroneous for the same reasons that an analogous calculation of ionised calcium is erroneous. Administration of magnesium should be monitored by measurement of the ionised magnesium concentration, which reflects the physiologically active fraction of magnesium and assists in detecting inactivation by complexing agents. It may help to decide whether patients may benefit from administration of magnesium and increased magnesium concentrations.
